Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« You Figure It Out | Main | Compounds for the Sake of Compounds »

May 25, 2005

The Voice of Experience

Email This Entry

Posted by Derek

During a meeting today, some of us were making a decision about whether or not to take a look at a particular series of compounds in some assays. I spoke up, saying "Hey, if we've got 'em, why not? Never talk yourself out of something that's easy to test."

"The voice of pragmatism", said someone else, and I responded "Darn right!" It's a real temptation in this business to think that you know more than you do. The alternative, a realistic appraisal of just how lost you (and everyone else) is, can be a bit disconcerting, and that's why I think people overvalue their expertise. "Those compounds never work," "We did something like that before," "We already know what the answer is" - these are the sounds that people make when they're trying to sound wiser than they probably are.

I have to look out for these tendencies in my own work, too. I've seen enough different sorts of projects that I do have some valuable experience to draw on. But not all of it is valuable all the time, and it's very hard to know when you're being fooled by a false correlation with something that's happened before. I don't know when something is going to be orally active, and I don't know what its blood levels are going to be like. Much as I would like to, I don't know exactly how a given compound binds to its protein target, and neither, in almost every case, does anyone else. I sure can't predict toxicity, either, and it's not for lack of motivation. One of the most valuable things I can take away from all my experience is the willingness to step back and let the results sort themselves out.

Now, there are times when you really shouldn't try something. But those times occur much less frequently than you'd think, and usually for lack of time or resources. But if both of those are available, I'm up for taking a flyer on all kinds of odd stuff. Some of the best things I've ever done looked pretty weird while I was doing them, that's for sure. But I'm at the point in my career where I'm less concerned about looking like a fool, so perhaps my best work is still to come.

Comments (3) + TrackBacks (0) | Category: Life in the Drug Labs


COMMENTS

1. J. Harris on May 26, 2005 5:28 AM writes...

You describe a very wise approach. Perhaps a large part of today's low productivity relative to dollars can be explained by having too many know-it-alls on board. I submit as evidence the commercial success of predictive PK and toxicology packages and the continued existence of Lipinski's rules.

Permalink to Comment

2. jeet on May 26, 2005 1:07 PM writes...

speaking of toxicitiy and other fairly unpredictable properties involved in drug development, maybe Derek could offer his thoughts on the risks of small molecule vs. protein/ antibody development.



I was mainly thinking about the effects that will knock a compound out of clinical testing. Of course there is a large possibility that I'm really reacting to Genetech's ridiculous hit rate over the last 12-18 months.


Permalink to Comment

3. PsychicChemist on May 26, 2005 7:40 PM writes...

I agree with the philosphy that "lets test them since we have them" because it is a lot lot easier to test compounds than it is to make them.

But I do not proscribe to the philosphy that "lets make them because we can".

I guess it goes back to the time of combichem and everyone knows how well that turned out.

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Academia and Industry, Suing Each Other
Let's Start Off the Meeting With An Ad, OK?
The Academic-Industrial Collaboration in Drug Discovery Panel: Today
Glass Structure, Atom by Atom
How the Andrulis Paper Got Published
AstraZeneca in Waltham
Fluorine NMR: Why Not?
AstraZeneca Layoffs and Closings